Rite Aid Stock Price, News & Analysis (NYSE:RAD)

$2.13 -0.07 (-3.18 %)
(As of 02/21/2018 10:31 AM ET)
Previous Close$2.20
Today's Range$2.10 - $2.19
52-Week Range$1.38 - $6.04
Volume13.35 million shs
Average Volume26.79 million shs
Market Capitalization$2.32 billion
P/E Ratio19.73
Dividend YieldN/A
Beta1.76

About Rite Aid (NYSE:RAD)

Rite Aid logoRite Aid Corporation is a retail drugstore chain. The Company's segments include Retail Pharmacy and Pharmacy Services. The Company operates under The Rite Aid name. It operates approximately 4,560 stores in over 30 states across the country and in the District of Columbia. The Company's Retail Pharmacy segment consists of Rite Aid stores, RediClinic and Health Dialog. It sells brand and generic prescription drugs, as well as an assortment of front-end products, including health and beauty aids, personal care products, seasonal merchandise, and a private brand product line. Its front-end products include over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise and numerous other everyday and convenience products. The Company's Pharmacy Services segment consists of EnvisionRx, which provides a range of pharmacy benefit services.

Receive RAD News and Ratings via Email

Sign-up to receive the latest news and ratings for RAD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Retail - Drugs without Grocery
Sub-IndustryDrug Retail
SectorNon-Cyclical Consumer Goods & Services
SymbolNYSE:RAD
CUSIP76775410
Phone+1-717-7612633

Debt

Debt-to-Equity Ratio3.66%
Current Ratio0.86%
Quick Ratio0.59%

Price-To-Earnings

Trailing P/E Ratio19.7272727272727
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$32.85 billion
Price / Sales0.07
Cash Flow$0.60 per share
Price / Cash3.53
Book Value$0.58 per share
Price / Book3.67

Profitability

Trailing EPS$0.11
Net Income$4.05 million
Net Margins0.53%
Return on Equity-10.19%
Return on Assets-0.61%

Miscellaneous

Employees87,000
Outstanding Shares1,067,510,000

Rite Aid (NYSE:RAD) Frequently Asked Questions

What is Rite Aid's stock symbol?

Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."

How were Rite Aid's earnings last quarter?

Rite Aid Co. (NYSE:RAD) announced its quarterly earnings results on Thursday, September, 28th. The company reported ($0.01) EPS for the quarter, hitting the Thomson Reuters' consensus estimate of ($0.01). The firm had revenue of $7.68 billion for the quarter, compared to analyst estimates of $7.83 billion. Rite Aid had a net margin of 0.53% and a negative return on equity of 10.19%. Rite Aid's revenue for the quarter was down 4.4% compared to the same quarter last year. During the same period last year, the business earned $0.03 EPS. View Rite Aid's Earnings History.

When will Rite Aid make its next earnings announcement?

Rite Aid is scheduled to release their next quarterly earnings announcement on Tuesday, April, 24th 2018. View Earnings Estimates for Rite Aid.

Where is Rite Aid's stock going? Where will Rite Aid's stock price be in 2018?

9 brokerages have issued 1-year price targets for Rite Aid's shares. Their forecasts range from $1.50 to $6.50. On average, they anticipate Rite Aid's stock price to reach $2.77 in the next twelve months. View Analyst Ratings for Rite Aid.

Are investors shorting Rite Aid?

Rite Aid saw a decline in short interest in the month of January. As of January 31st, there was short interest totalling 143,458,714 shares, a decline of 8.8% from the January 12th total of 157,377,704 shares. Based on an average daily trading volume, of 19,487,817 shares, the days-to-cover ratio is currently 7.4 days. Approximately 13.6% of the company's shares are sold short.

Who are some of Rite Aid's key competitors?

Who are Rite Aid's key executives?

Rite Aid's management team includes the folowing people:

  • John T. Standley, Chairman of the Board, Chief Executive Officer (Age 54)
  • Kermit Crawford, President, Chief Operating Officer (Age 58)
  • Darren W. Karst, Chief Financial Officer, Senior Executive Vice President, Chief Administrative Officer (Age 57)
  • Bryan Everett, Chief Operating Officer (Age 44)
  • David Abelman, Executive Vice President - Marketing (Age 57)
  • Derek Griffith, Executive Vice President - Store Operations
  • Jocelyn Z. Konrad, Executive Vice President - Pharmacy (Age 47)
  • Matt Schroeder, Senior Vice President, Chief Accounting Officer, Treasurer
  • Michael N. Regan, Lead Independent Director (Age 69)
  • Joseph B. Anderson Jr., Independent Director (Age 72)

Who owns Rite Aid stock?

Rite Aid's stock is owned by a variety of of institutional and retail investors. Top institutional investors include OppenheimerFunds Inc. (4.96%), Franklin Resources Inc. (3.94%), Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp (1.54%), Geode Capital Management LLC (0.81%), California Public Employees Retirement System (0.45%) and Bank of New York Mellon Corp (0.38%). Company insiders that own Rite Aid stock include Douglas E Donley and Myrtle S Potter. View Institutional Ownership Trends for Rite Aid.

Who sold Rite Aid stock? Who is selling Rite Aid stock?

Rite Aid's stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Quinn Opportunity Partners LLC, GABELLI & Co INVESTMENT ADVISERS INC., Deutsche Bank AG, Symons Capital Management Inc., Cowen Inc., Gabelli Funds LLC and Geode Capital Management LLC. View Insider Buying and Selling for Rite Aid.

Who bought Rite Aid stock? Who is buying Rite Aid stock?

Rite Aid's stock was acquired by a variety of institutional investors in the last quarter, including OppenheimerFunds Inc., Element Capital Management LLC, Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp, SG Americas Securities LLC, State of Wisconsin Investment Board, Two Sigma Investments LP, California Public Employees Retirement System and North Fourth Asset Management LP. View Insider Buying and Selling for Rite Aid.

How do I buy Rite Aid stock?

Shares of Rite Aid can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Rite Aid's stock price today?

One share of Rite Aid stock can currently be purchased for approximately $2.13.

How big of a company is Rite Aid?

Rite Aid has a market capitalization of $2.32 billion and generates $32.85 billion in revenue each year. The company earns $4.05 million in net income (profit) each year or $0.11 on an earnings per share basis. Rite Aid employs 87,000 workers across the globe.

How can I contact Rite Aid?

Rite Aid's mailing address is 30 Hunter Ln, CAMP HILL, PA 17011-2400, United States. The company can be reached via phone at +1-717-7612633 or via email at [email protected]


MarketBeat Community Rating for Rite Aid (RAD)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  362 (Vote Outperform)
Underperform Votes:  347 (Vote Underperform)
Total Votes:  709
MarketBeat's community ratings are surveys of what our community members think about Rite Aid and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Rite Aid (NYSE:RAD) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.002.002.002.00
Ratings Breakdown: 2 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $2.77$2.77$3.36$4.19
Price Target Upside: 33.28% upside33.28% upside88.51% upside59.38% upside

Rite Aid (NYSE:RAD) Consensus Price Target History

Price Target History for Rite Aid (NYSE:RAD)

Rite Aid (NYSE:RAD) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/4/2018Evercore ISIInitiated CoverageUnderperform -> Underperform$1.50MediumView Rating Details
12/4/2017Deutsche BankInitiated CoverageHold$2.25MediumView Rating Details
10/25/2017Royal Bank of CanadaSet Price TargetHold$2.00N/AView Rating Details
10/7/2017MizuhoSet Price TargetHold$2.00N/AView Rating Details
10/2/2017GuggenheimReiterated RatingNeutral$2.00LowView Rating Details
9/29/2017Loop CapitalReiterated RatingHold -> Hold$2.50 -> $2.00HighView Rating Details
7/3/2017CowenReiterated RatingOutperform$4.70HighView Rating Details
6/30/2017Bank of AmericaReiterated RatingUnderperform$2.00HighView Rating Details
3/20/2017Credit Suisse GroupReiterated RatingOutperform$6.50LowView Rating Details
6/17/2016JPMorgan Chase & Co.Reiterated RatingHoldN/AView Rating Details
(Data available from 2/21/2016 forward)

Earnings

Rite Aid (NYSE:RAD) Earnings History and Estimates Chart

Earnings by Quarter for Rite Aid (NYSE:RAD)

Rite Aid (NYSE RAD) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/24/2018        
9/28/2017Q2 2018($0.01)($0.01)$7.83 billion$7.68 billionViewN/AView Earnings Details
6/29/2017Q1 2018($0.01)($0.05)$8.29 billion$7.78 billionViewN/AView Earnings Details
12/22/2016Q317$0.04$0.02$8.23 billion$8.09 billionViewN/AView Earnings Details
9/22/2016Q2$0.03$0.03$8.09 billion$8.03 billionViewN/AView Earnings Details
6/16/2016Q117$0.05$0.01$8.23 billion$8.18 billionViewN/AView Earnings Details
4/7/2016Q416$0.06$0.07$8.47 billion$8.27 billionViewN/AView Earnings Details
12/17/2015Q316$0.06$0.06$8.20 billion$8.15 billionViewN/AView Earnings Details
9/17/2015Q216$0.03$0.02$7.60 billion$7.66 billionViewListenView Earnings Details
6/18/2015Q116$0.03$0.04$6.65 billion$6.60 billionViewListenView Earnings Details
4/8/2015Q415$0.07$0.12$6.79 billion$6.85 billionViewN/AView Earnings Details
12/18/2014Q315$0.05$0.10$6.55 billion$6.70 billionViewListenView Earnings Details
9/18/2014Q215$0.06$0.13$6.49 billion$6.52 billionViewListenView Earnings Details
6/19/2014Q115$0.05$0.04$6.43 billion$6.47 billionViewListenView Earnings Details
4/10/2014Q414$0.04$0.10$6.54 billion$6.60 billionViewListenView Earnings Details
12/19/2013Q314$0.04$0.04$6.30 billion$6.36 billionViewListenView Earnings Details
9/19/2013Q2 2014($0.04)$0.03$6.27 billion$6.30 billionViewListenView Earnings Details
6/20/2013Q1 2014$0.09$0.09$6.27 billion$6.30 billionViewListenView Earnings Details
4/11/2013Q4 2013($0.02)$0.13$6.47 billion$6.50 billionViewListenView Earnings Details
12/20/2012Q3 2013($0.03)$0.07$6.28 billion$6.24 billionViewListenView Earnings Details
9/20/2012Q213($0.07)($0.05)$6.20 billion$6.20 billionViewN/AView Earnings Details
6/21/2012($0.03)($0.03)ViewN/AView Earnings Details
4/12/2012($0.17)($0.18)ViewN/AView Earnings Details
12/15/2011($0.13)($0.06)ViewN/AView Earnings Details
9/22/2011($0.17)($0.11)ViewN/AView Earnings Details
6/23/2011($0.12)($0.07)ViewN/AView Earnings Details
4/7/2011($0.24)($0.24)ViewN/AView Earnings Details
12/16/2010($0.13)($0.09)$6.20 billion$6.20 billionViewN/AView Earnings Details
9/23/2010Q2 2011($0.16)($0.18)ViewN/AView Earnings Details
6/23/2010Q1 2011($0.14)($0.09)ViewN/AView Earnings Details
3/31/2010Q4 2010($0.19)($0.24)ViewN/AView Earnings Details
12/17/2009Q3 2010($0.18)($0.10)ViewN/AView Earnings Details
9/24/2009Q2 2010($0.15)($0.14)ViewN/AView Earnings Details
6/24/2009Q1 2010($0.13)($0.11)ViewN/AView Earnings Details
4/2/2009Q4 2009($0.11)($0.14)ViewN/AView Earnings Details
12/18/2008Q3 2009($0.17)($0.17)ViewN/AView Earnings Details
9/25/2008Q2 2009($0.14)($0.27)ViewN/AView Earnings Details
6/26/2008Q1 2009($0.09)($0.20)ViewN/AView Earnings Details
4/10/2008Q4 2008($0.07)($0.07)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Rite Aid (NYSE:RAD) Earnings Estimates

2018 EPS Consensus Estimate: $0.22
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.03$0.03$0.03
Q2 20181$0.04$0.04$0.04
Q3 20181$0.08$0.08$0.08
Q4 20181$0.07$0.07$0.07
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Rite Aid (NYSE:RAD)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Rite Aid (NYSE RAD) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.29%
Institutional Ownership Percentage: 51.68%
Insider Trades by Quarter for Rite Aid (NYSE:RAD)
Institutional Ownership by Quarter for Rite Aid (NYSE:RAD)

Rite Aid (NYSE RAD) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/3/2017Myrtle S PotterDirectorSell28,189$2.09$58,915.01View SEC Filing  
6/15/2016Douglas E DonleySVPSell34,106$7.77$265,003.6282,885View SEC Filing  
7/9/2015Tony MontiniEVPSell353,194$8.38$2,959,765.72View SEC Filing  
4/15/2015Joseph B Anderson JrDirectorSell150,000$8.25$1,237,500.00View SEC Filing  
4/13/2015Robert K ThompsonEVPSell95,850$8.33$798,430.50View SEC Filing  
4/10/2015Douglas E DonleyCAOSell59,404$8.21$487,706.84View SEC Filing  
4/10/2015Marcy SymsDirectorSell150,000$8.26$1,239,000.00View SEC Filing  
12/29/2014Tony MontiniEVPSell49,525$7.47$369,951.75View SEC Filing  
12/23/2014Tony MontiniEVPSell259,750$6.92$1,797,470.00View SEC Filing  
12/22/2014John T StandleyCEOSell1,700,000$6.82$11,594,000.00View SEC Filing  
12/22/2014Kenneth MartindaleCOOSell1,043,400$6.80$7,095,120.00View SEC Filing  
12/22/2014Robert Ivan ThompsonEVPSell149,231$6.80$1,014,770.80View SEC Filing  
7/3/2014Robert Ivan ThompsonEVPSell249,583$7.48$1,866,880.84View SEC Filing  
6/24/2014Joseph B Anderson JrDirectorSell26,667$7.05$188,002.35View SEC Filing  
6/23/2014Robert Ivan ThompsonEVPSell510,000$7.06$3,600,600.00View SEC Filing  
4/22/2014Marc StrasslerEVPSell224,800$7.12$1,600,576.00699,369View SEC Filing  
4/21/2014Frank VitranoEVPSell1,913,925$7.08$13,550,589.001,183,384View SEC Filing  
4/16/2014Robert Ivan ThompsonEVPSell25,566$7.03$179,728.98749,882View SEC Filing  
2/19/2014John StandleyCEOSell1,200,000$6.23$7,476,000.002,974,958View SEC Filing  
2/19/2014Kenneth MartindaleCOOSell666,667$6.23$4,153,335.411,193,252View SEC Filing  
1/21/2014Douglas DonleySVPSell24,173$5.79$139,961.6781,628View SEC Filing  
1/3/2014John StandleyCEOSell600,000$5.48$3,288,000.002,974,958View SEC Filing  
1/3/2014Kenneth MartindaleCOOSell333,333$5.48$1,826,664.841,193,252View SEC Filing  
10/18/2013Robert K ThompsonEVPSell250,000$5.27$1,317,500.00View SEC Filing  
10/17/2013Douglas E DonleySVPSell88,700$5.27$467,449.00View SEC Filing  
10/17/2013Marc A StrasslerEVPSell100,000$5.31$531,000.00View SEC Filing  
10/14/2013Frank VitranoCFOSell1,982,900$5.00$9,914,500.001,183,384View SEC Filing  
10/4/2013Tony MontiniEVPSell414,500$5.21$2,159,545.00643,713View SEC Filing  
9/25/2013Robert Ivan ThompsonEVPSell400,000$4.81$1,924,000.00749,882View SEC Filing  
7/18/2013Robert K ThompsonEVPSell401,655$3.01$1,208,981.55View SEC Filing  
7/16/2013David JessickInsiderSell100,000$2.93$293,000.00View SEC Filing  
7/16/2013Marc A StrasslerEVPSell375,000$2.96$1,110,000.00View SEC Filing  
7/12/2013Douglas E DonleySVPSell6,899$2.80$19,317.20View SEC Filing  
7/11/2013Douglas E DonleySVPSell75,378$2.78$209,550.84View SEC Filing  
7/11/2013Robert Ivan ThompsonEVPSell375,000$2.75$1,031,250.00View SEC Filing  
6/26/2013Jean Coutu Group (Pjc) Inc.Major ShareholderSell40,500,000$2.75$111,375,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Rite Aid (NYSE RAD) News Headlines

Source:
DateHeadline
Albertson’s Buyout Is a Terrible Deal for Rite Aid Stock OwnersAlbertson’s Buyout Is a Terrible Deal for Rite Aid Stock Owners
investorplace.com - February 21 at 7:31 AM
Amazon has quietly launched an exclusive line of over-the-counter health products - Yahoo FinanceAmazon has quietly launched an exclusive line of over-the-counter health products - Yahoo Finance
finance.yahoo.com - February 21 at 5:21 AM
Business HighlightsBusiness Highlights
marketbeat.com - February 20 at 6:17 PM
Gap and Walmart slump while NXP and Rite Aid riseGap and Walmart slump while NXP and Rite Aid rise
marketbeat.com - February 20 at 5:00 PM
Real estate owner Kimco to benefit from Albertsons acquisition of Rite AidReal estate owner Kimco to benefit from Albertsons' acquisition of Rite Aid
www.cnbc.com - February 20 at 3:27 PM
Albertsons will buy chunk of Rite Aid that isnt going to Walgreens: WSJ - Reuters.comAlbertsons will buy chunk of Rite Aid that isn't going to Walgreens: WSJ - Reuters.com
www.reuters.com - February 20 at 3:08 PM
Rite Aid (RAD) Shares Worth About $0.75 to $1.75 Per Share - Evercore - StreetInsider.comRite Aid (RAD) Shares Worth About $0.75 to $1.75 Per Share - Evercore - StreetInsider.com
www.streetinsider.com - February 20 at 3:08 PM
Albertsons, Rite Aid deal creates US supermarket and healthcare giant - USA TODAYAlbertsons, Rite Aid deal creates US supermarket and healthcare giant - USA TODAY
www.usatoday.com - February 20 at 3:08 PM
Kimco Realty Rings The Register With Albertson/Rite Aid Merger - ForbesKimco Realty Rings The Register With Albertson/Rite Aid Merger - Forbes
www.forbes.com - February 20 at 3:08 PM
INSERTING and REPLACING RITE AID CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of BuyoutINSERTING and REPLACING RITE AID CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout
finance.yahoo.com - February 20 at 3:08 PM
Grocery operator Albertsons is buying the Rite Aid drugstore chainGrocery operator Albertsons is buying the Rite Aid drugstore chain
www.latimes.com - February 20 at 2:13 PM
Is Rite Aid Corporation Stock Being Bought Out at $6 or $2.50?Is Rite Aid Corporation Stock Being Bought Out at $6 or $2.50?
investorplace.com - February 20 at 12:23 PM
Albertsons/Rite Aid tie-up positive for McKesson - NeedhamAlbertsons/Rite Aid tie-up positive for McKesson - Needham
seekingalpha.com - February 20 at 10:18 AM
US stocks are mostly lower as markets reopen after holidayUS stocks are mostly lower as markets reopen after holiday
marketbeat.com - February 20 at 10:17 AM
The Market In 5 Minutes: Albertsons-Rite Aid, Snap Downgrade, South Korean Crypto Regulator Found DeadThe Market In 5 Minutes: Albertsons-Rite Aid, Snap Downgrade, South Korean Crypto Regulator Found Dead
feeds.benzinga.com - February 20 at 9:49 AM
Rite Aid, Albertsons plan $24B mergerRite Aid, Albertsons plan $24B merger
seekingalpha.com - February 20 at 8:15 AM
Grocery retailer Albertsons to buy drugstore chain Rite AidGrocery retailer Albertsons to buy drugstore chain Rite Aid
marketbeat.com - February 20 at 7:58 AM
Grocery chain Albertsons to acquire Rite Aid in defense move against AmazonGrocery chain Albertsons to acquire Rite Aid in defense move against Amazon
www.cnbc.com - February 20 at 5:46 AM
Albertsons will buy chunk of Rite Aid that isnt going to Walgreens: WSJ - ReutersAlbertsons will buy chunk of Rite Aid that isn't going to Walgreens: WSJ - Reuters
www.reuters.com - February 20 at 5:21 AM
Albertsons Swoops for Rite Aid as Retailers Face Online Threat - Wall Street JournalAlbertsons Swoops for Rite Aid as Retailers Face Online Threat - Wall Street Journal
www.wsj.com - February 20 at 5:21 AM
[$$] Albertsons and Rite Aid to Combine[$$] Albertsons and Rite Aid to Combine
finance.yahoo.com - February 20 at 5:21 AM
Albertsons will buy chunk of Rite Aid that isnt going to Walgreens: WSJAlbertsons will buy chunk of Rite Aid that isn't going to Walgreens: WSJ
finance.yahoo.com - February 20 at 5:21 AM
The Wall Street Journal: Albertsons to buy remainder of Rite AidThe Wall Street Journal: Albertsons to buy remainder of Rite Aid
www.marketwatch.com - February 20 at 4:10 AM
General Nutrition Centers, Inc. -- Moodys assigns (P)B3 to GNCs proposed term loan; places Caa1 CFR on review for upgradeGeneral Nutrition Centers, Inc. -- Moody's assigns (P)B3 to GNC's proposed term loan; places Caa1 CFR on review for upgrade
finance.yahoo.com - February 14 at 3:10 PM
Flu Shots Available at Rite Aid as Severe Flu Season Continues - Business Wire (press release)Flu Shots Available at Rite Aid as Severe Flu Season Continues - Business Wire (press release)
www.businesswire.com - February 13 at 5:08 AM
Rite Aid: Destination Insignificance - Rite Aid Corporation (NYSE ... - Seeking AlphaRite Aid: Destination Insignificance - Rite Aid Corporation (NYSE ... - Seeking Alpha
seekingalpha.com - February 13 at 5:08 AM
Rite Aid Co. (RAD) Short Interest UpdateRite Aid Co. (RAD) Short Interest Update
www.americanbankingnews.com - February 13 at 2:40 AM
Flu Shots Available at Rite Aid as Severe Flu Season ContinuesFlu Shots Available at Rite Aid as Severe Flu Season Continues
finance.yahoo.com - February 12 at 3:06 PM
Follow Cupids Arrow Straight to Rite Aid for One-Stop Valentines Day Shopping - Business Wire (press release)Follow Cupid's Arrow Straight to Rite Aid for One-Stop Valentine's Day Shopping - Business Wire (press release)
www.businesswire.com - February 10 at 3:03 PM
Today’s Research Reports on Stocks to Watch: Rite Aid and CVS HealthToday’s Research Reports on Stocks to Watch: Rite Aid and CVS Health
finance.yahoo.com - February 9 at 3:10 PM
Follow Cupid’s Arrow Straight to Rite Aid for One-Stop Valentine’s Day ShoppingFollow Cupid’s Arrow Straight to Rite Aid for One-Stop Valentine’s Day Shopping
finance.yahoo.com - February 9 at 3:10 PM
Rite Aid (RAD) Reports Continued Progress on Plan to Sell Stores to Walgreens Boots Alliance (WBA) - StreetInsider.comRite Aid (RAD) Reports Continued Progress on Plan to Sell Stores to Walgreens Boots Alliance (WBA) - StreetInsider.com
www.streetinsider.com - February 9 at 5:00 AM
Rite Aid Says Its Halfway Home On Store Transfers To WalgreensRite Aid Says It's Halfway Home On Store Transfers To Walgreens
finance.yahoo.com - February 9 at 5:00 AM
Rite Aid Announces Continued Progress in Sale of Assets to Walgreens Boots AllianceRite Aid Announces Continued Progress in Sale of Assets to Walgreens Boots Alliance
finance.yahoo.com - February 9 at 5:00 AM
Rite Aid (RAD) a Strong Sell at recent price of $2.07, on Funereal Sales Growth - Investorplace.comRite Aid (RAD) a Strong Sell at recent price of $2.07, on Funereal Sales Growth - Investorplace.com
investorplace.com - February 8 at 3:08 PM
Rite Aid (RAD) a Strong Sell at recent price of $2.07, on Funereal Sales GrowthRite Aid (RAD) a Strong Sell at recent price of $2.07, on Funereal Sales Growth
investorplace.com - February 7 at 12:39 PM
Hudson’s Bay Poaches Helena Foulkes From CVSHudson’s Bay Poaches Helena Foulkes From CVS
finance.yahoo.com - February 6 at 5:02 AM
Hudsons Bay Poaches Helena Foulkes From CVS - FortuneHudson's Bay Poaches Helena Foulkes From CVS - Fortune
fortune.com - February 5 at 3:07 PM
Rite Aid (RAD) Upgraded to Hold by Zacks Investment ResearchRite Aid (RAD) Upgraded to Hold by Zacks Investment Research
www.americanbankingnews.com - February 5 at 1:10 PM
"Fast Money" final trades: RACE, GS, and more"Fast Money" final trades: RACE, GS, and more
finance.yahoo.com - February 3 at 5:14 AM
Rite Aid Co. (RAD) Receives Consensus Rating of "Hold" from AnalystsRite Aid Co. (RAD) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - February 2 at 5:30 PM
Rite Aids Turnaround Is Inevitable - Seeking AlphaRite Aid's Turnaround Is Inevitable - Seeking Alpha
seekingalpha.com - February 1 at 3:00 PM
Low-End Quant Score Make Rite Aid (RAD) a Strong Sell at recent price of $2.08 - Investorplace.comLow-End Quant Score Make Rite Aid (RAD) a Strong Sell at recent price of $2.08 - Investorplace.com
investorplace.com - January 31 at 3:09 PM
GM, McDonalds, Rite Aid, Starbucks: Fast Money Picks For January 31 - BenzingaGM, McDonald's, Rite Aid, Starbucks: 'Fast Money' Picks For January 31 - Benzinga
www.benzinga.com - January 31 at 3:09 PM
Why Walgreens Boots Alliance Fell 5% Today - Motley FoolWhy Walgreens Boots Alliance Fell 5% Today - Motley Fool
www.fool.com - January 31 at 5:06 AM
"Fast Money" final trades: SBUX, GM and more"Fast Money" final trades: SBUX, GM and more
finance.yahoo.com - January 31 at 5:06 AM
Rite Aid (RAD) Lifted to "Strong-Buy" at VetrRite Aid (RAD) Lifted to "Strong-Buy" at Vetr
www.americanbankingnews.com - January 28 at 11:06 AM
Today’s Research Reports on Trending Tickers: Rite Aid and Wal-MartToday’s Research Reports on Trending Tickers: Rite Aid and Wal-Mart
finance.yahoo.com - January 25 at 3:01 PM
Rite Aid (RAD) on Track with Asset Sale: Is it Aiding Stock? - Yahoo FinanceRite Aid (RAD) on Track with Asset Sale: Is it Aiding Stock? - Yahoo Finance
finance.yahoo.com - January 23 at 3:16 PM
Rite Aid (RAD) on Track with Asset Sale: Is it Aiding Stock? - NasdaqRite Aid (RAD) on Track with Asset Sale: Is it Aiding Stock? - Nasdaq
www.nasdaq.com - January 23 at 7:44 AM

SEC Filings

Rite Aid (NYSE:RAD) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Rite Aid (NYSE:RAD) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Rite Aid (NYSE RAD) Stock Chart for Wednesday, February, 21, 2018

Loading chart…

This page was last updated on 2/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.